OBJECTIVE: To describe the use of thromboelastography (TEG) to direct hemostatic resuscitation in a child with traumatic injury requiring massive transfusion. DESIGN: Case report. SETTING: Level 1 pediatric trauma center in an academic tertiary care facility. PATIENT: A 5-year-old boy with grade IV liver injury and right common hepatic artery laceration. INTERVENTION: TEG-directed resuscitation, including recombinant activated factor VII. MEASUREMENTS AND MAIN RESULTS: Measurements included vital signs, laboratory results to include TEG values, and blood product administration. TEG-directed resuscitation with recombinant activated factor VII was associated with the prevention of increased intracranial hemorrhage and survival in a coagulopathic patient with a life-threatening traumatic injury. CONCLUSION: Our clinical and TEG laboratory results postresuscitation support the potential use of TEG as a tool to direct hemostatic resuscitation in patients with severe trauma requiring massive transfusion. TEG is a quick and focused method of qualitatively assessing the entire coagulation cascade, from clot formation to fibrinolysis that permits a targeted transfusion approach to the treatment of coagulopathy. TEG has the potential to rapidly and effectively direct hemostatic resuscitation in patients with the coagulopathy of trauma.
OBJECTIVE: To describe the use of thromboelastography (TEG) to direct hemostatic resuscitation in a child with traumatic injury requiring massive transfusion. DESIGN: Case report. SETTING: Level 1 pediatric trauma center in an academic tertiary care facility. PATIENT: A 5-year-old boy with grade IV liver injury and right common hepatic artery laceration. INTERVENTION: TEG-directed resuscitation, including recombinant activated factor VII. MEASUREMENTS AND MAIN RESULTS: Measurements included vital signs, laboratory results to include TEG values, and blood product administration. TEG-directed resuscitation with recombinant activated factor VII was associated with the prevention of increased intracranial hemorrhage and survival in a coagulopathic patient with a life-threatening traumatic injury. CONCLUSION: Our clinical and TEG laboratory results postresuscitation support the potential use of TEG as a tool to direct hemostatic resuscitation in patients with severe trauma requiring massive transfusion. TEG is a quick and focused method of qualitatively assessing the entire coagulation cascade, from clot formation to fibrinolysis that permits a targeted transfusion approach to the treatment of coagulopathy. TEG has the potential to rapidly and effectively direct hemostatic resuscitation in patients with the coagulopathy of trauma.
Authors: Mark Walsh; Scott G Thomas; Janet C Howard; Edward Evans; Kirk Guyer; Andrew Medvecz; Andrew Swearingen; Rudolph M Navari; Victoria Ploplis; Francis J Castellino Journal: J Extra Corpor Technol Date: 2011-09
Authors: Sarah C Christiaans; Amy L Duhachek-Stapelman; Robert T Russell; Steven J Lisco; Jeffrey D Kerby; Jean-François Pittet Journal: Shock Date: 2014-06 Impact factor: 3.454
Authors: Dongngan T Truong; Joyce T Johnson; David K Bailly; Jason R Clawson; Xiaoming Sheng; Phillip T Burch; Madolin K Witte; L LuAnn Minich Journal: Pediatr Cardiol Date: 2016-12-30 Impact factor: 1.655
Authors: Manuel Burggraf; Christina Polan; Martin Husen; Bastian Mester; Alexander Wegner; Daniel Spodeck; Marcel Dudda; Max Daniel Kauther Journal: World J Emerg Surg Date: 2020-05-06 Impact factor: 5.469